Shaikh Atif
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
CD4-Positive T-Lymphocytes | 12 | 2025 | 1056 | 2.440 |
Why?
| Berylliosis | 6 | 2025 | 185 | 2.120 |
Why?
| Sarcoidosis | 4 | 2024 | 156 | 1.760 |
Why?
| Dendritic Cells | 8 | 2020 | 478 | 1.650 |
Why?
| Flagellin | 6 | 2020 | 17 | 1.350 |
Why?
| Lung Injury | 2 | 2022 | 210 | 1.170 |
Why?
| B-Lymphocytes | 3 | 2025 | 815 | 1.150 |
Why?
| Adaptive Immunity | 7 | 2022 | 161 | 1.070 |
Why?
| Lung | 9 | 2025 | 3931 | 1.010 |
Why?
| Receptors, Interleukin-1 Type I | 1 | 2025 | 24 | 0.940 |
Why?
| Monocytes | 5 | 2021 | 551 | 0.880 |
Why?
| Renin-Angiotensin System | 1 | 2024 | 82 | 0.880 |
Why?
| Macrophages, Alveolar | 5 | 2020 | 389 | 0.850 |
Why?
| Beryllium | 5 | 2025 | 152 | 0.750 |
Why?
| HLA-DP beta-Chains | 3 | 2021 | 84 | 0.700 |
Why?
| Salmonella Infections | 3 | 2020 | 54 | 0.690 |
Why?
| Signal Transduction | 6 | 2025 | 4925 | 0.680 |
Why?
| Salmonella typhimurium | 4 | 2020 | 175 | 0.680 |
Why?
| Mice, Knockout | 10 | 2025 | 2871 | 0.630 |
Why?
| Melanoma, Experimental | 1 | 2018 | 108 | 0.580 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2025 | 442 | 0.560 |
Why?
| Mice | 24 | 2025 | 16937 | 0.560 |
Why?
| CD11b Antigen | 2 | 2018 | 60 | 0.560 |
Why?
| Immunoglobulin M | 1 | 2018 | 275 | 0.550 |
Why?
| Membrane Lipids | 2 | 2008 | 91 | 0.530 |
Why?
| Spermatozoa | 2 | 2008 | 91 | 0.530 |
Why?
| Mice, Inbred C57BL | 15 | 2025 | 5440 | 0.520 |
Why?
| Basic-Leucine Zipper Transcription Factors | 2 | 2016 | 41 | 0.510 |
Why?
| Liposomes | 2 | 2008 | 168 | 0.510 |
Why?
| Antigens, Neoplasm | 1 | 2018 | 309 | 0.510 |
Why?
| CD8-Positive T-Lymphocytes | 3 | 2018 | 857 | 0.490 |
Why?
| Cell Culture Techniques | 1 | 2018 | 345 | 0.490 |
Why?
| Minor Histocompatibility Antigens | 1 | 2015 | 46 | 0.470 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2014 | 19 | 0.470 |
Why?
| Animals | 30 | 2025 | 35361 | 0.460 |
Why?
| Skin Transplantation | 1 | 2015 | 84 | 0.460 |
Why?
| Salmonella typhi | 1 | 2014 | 13 | 0.450 |
Why?
| Lymph Nodes | 4 | 2020 | 472 | 0.430 |
Why?
| Biomarkers | 2 | 2024 | 3973 | 0.430 |
Why?
| Antigens, Bacterial | 1 | 2014 | 119 | 0.430 |
Why?
| Integrin alpha Chains | 1 | 2013 | 23 | 0.420 |
Why?
| Repressor Proteins | 2 | 2016 | 406 | 0.400 |
Why?
| Toll-Like Receptor 5 | 4 | 2014 | 14 | 0.400 |
Why?
| Inflammation | 6 | 2025 | 2736 | 0.390 |
Why?
| Granuloma | 3 | 2022 | 89 | 0.380 |
Why?
| Mice, Transgenic | 9 | 2025 | 2119 | 0.370 |
Why?
| Graft Rejection | 1 | 2015 | 598 | 0.370 |
Why?
| Protein-Tyrosine Kinases | 1 | 2014 | 432 | 0.360 |
Why?
| Immunity, Innate | 5 | 2025 | 804 | 0.360 |
Why?
| Antigens | 3 | 2021 | 355 | 0.360 |
Why?
| Antigens, CD | 1 | 2013 | 489 | 0.340 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 821 | 0.340 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 2021 | 135 | 0.320 |
Why?
| Phagocytes | 3 | 2020 | 97 | 0.320 |
Why?
| Macrophages | 6 | 2021 | 1480 | 0.300 |
Why?
| Disease Models, Animal | 4 | 2025 | 4063 | 0.290 |
Why?
| Myeloid Differentiation Factor 88 | 3 | 2019 | 96 | 0.280 |
Why?
| Adjuvants, Immunologic | 1 | 2008 | 221 | 0.270 |
Why?
| Chronic Disease | 5 | 2025 | 1720 | 0.270 |
Why?
| Epitopes, T-Lymphocyte | 2 | 2021 | 186 | 0.260 |
Why?
| Sperm-Ovum Interactions | 1 | 2006 | 12 | 0.260 |
Why?
| Membrane Fusion | 1 | 2006 | 38 | 0.250 |
Why?
| Lung Neoplasms | 1 | 2018 | 2344 | 0.250 |
Why?
| Receptors, CXCR5 | 1 | 2025 | 20 | 0.240 |
Why?
| Oocytes | 1 | 2006 | 176 | 0.240 |
Why?
| Plastics | 1 | 2025 | 47 | 0.230 |
Why?
| Spleen | 3 | 2016 | 507 | 0.220 |
Why?
| Membrane Proteins | 3 | 2018 | 1119 | 0.210 |
Why?
| Lymphocyte Activation | 3 | 2018 | 1106 | 0.210 |
Why?
| Trophoblasts | 1 | 2025 | 190 | 0.210 |
Why?
| Cytokines | 5 | 2020 | 2017 | 0.200 |
Why?
| Fetal Development | 1 | 2025 | 288 | 0.190 |
Why?
| Wnt Signaling Pathway | 1 | 2023 | 170 | 0.190 |
Why?
| Aspergillus nidulans | 1 | 2021 | 6 | 0.190 |
Why?
| Antigen Presentation | 3 | 2014 | 206 | 0.190 |
Why?
| Chemokine CCL3 | 1 | 2021 | 17 | 0.180 |
Why?
| Chemokine CCL4 | 1 | 2021 | 23 | 0.180 |
Why?
| Group VI Phospholipases A2 | 1 | 2020 | 6 | 0.180 |
Why?
| Nanoparticles | 1 | 2025 | 374 | 0.180 |
Why?
| Cells, Cultured | 4 | 2020 | 4083 | 0.170 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2020 | 182 | 0.170 |
Why?
| Interferon Type I | 1 | 2020 | 139 | 0.160 |
Why?
| Tertiary Lymphoid Structures | 1 | 2019 | 6 | 0.160 |
Why?
| Chemokine CXCL13 | 1 | 2019 | 7 | 0.160 |
Why?
| Genome, Viral | 1 | 2020 | 129 | 0.160 |
Why?
| Calcium-Binding Proteins | 1 | 2020 | 210 | 0.160 |
Why?
| Colitis | 1 | 2021 | 242 | 0.160 |
Why?
| Gene Expression Regulation | 3 | 2020 | 2548 | 0.160 |
Why?
| Sarcoidosis, Pulmonary | 1 | 2020 | 83 | 0.160 |
Why?
| CD40 Ligand | 1 | 2018 | 38 | 0.150 |
Why?
| Intestinal Mucosa | 1 | 2023 | 590 | 0.150 |
Why?
| Antigen-Presenting Cells | 1 | 2018 | 150 | 0.150 |
Why?
| Bacterial Proteins | 2 | 2014 | 835 | 0.150 |
Why?
| Thermolysin | 1 | 2018 | 4 | 0.150 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1706 | 0.150 |
Why?
| Chemokines | 1 | 2019 | 226 | 0.150 |
Why?
| Collagenases | 1 | 2018 | 23 | 0.150 |
Why?
| Pancreatic Elastase | 1 | 2018 | 60 | 0.140 |
Why?
| CD11c Antigen | 1 | 2018 | 41 | 0.140 |
Why?
| c-Mer Tyrosine Kinase | 1 | 2018 | 44 | 0.140 |
Why?
| Receptors, IgG | 1 | 2018 | 74 | 0.140 |
Why?
| T-Lymphocyte Subsets | 1 | 2020 | 412 | 0.140 |
Why?
| Betacoronavirus | 1 | 2020 | 249 | 0.140 |
Why?
| Flow Cytometry | 3 | 2016 | 1156 | 0.140 |
Why?
| Inflammasomes | 2 | 2020 | 126 | 0.140 |
Why?
| Bacterial Load | 2 | 2014 | 66 | 0.140 |
Why?
| Lymphocytes | 1 | 2019 | 377 | 0.140 |
Why?
| Ovalbumin | 3 | 2016 | 179 | 0.130 |
Why?
| Anti-Inflammatory Agents | 1 | 2020 | 480 | 0.130 |
Why?
| Cell Proliferation | 3 | 2014 | 2391 | 0.130 |
Why?
| Mononuclear Phagocyte System | 1 | 2016 | 11 | 0.130 |
Why?
| Antigens, Ly | 1 | 2016 | 44 | 0.130 |
Why?
| Lung Diseases | 1 | 2022 | 742 | 0.120 |
Why?
| Histocompatibility Testing | 1 | 2015 | 120 | 0.120 |
Why?
| Syk Kinase | 1 | 2014 | 21 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2020 | 1198 | 0.120 |
Why?
| Receptors, Immunologic | 2 | 2015 | 216 | 0.120 |
Why?
| Phagosomes | 1 | 2014 | 42 | 0.120 |
Why?
| Receptors, Interleukin-2 | 1 | 2014 | 66 | 0.120 |
Why?
| Humans | 16 | 2025 | 129652 | 0.120 |
Why?
| Adoptive Transfer | 1 | 2015 | 218 | 0.110 |
Why?
| Germinal Center | 1 | 2014 | 57 | 0.110 |
Why?
| Mice, Inbred BALB C | 2 | 2008 | 1245 | 0.110 |
Why?
| Protease Inhibitors | 2 | 2005 | 106 | 0.110 |
Why?
| Lysosomes | 1 | 2014 | 138 | 0.110 |
Why?
| Transplantation, Homologous | 1 | 2015 | 401 | 0.110 |
Why?
| Female | 11 | 2025 | 68777 | 0.110 |
Why?
| Immunoglobulin G | 3 | 2021 | 847 | 0.110 |
Why?
| Interleukin-2 | 1 | 2014 | 436 | 0.100 |
Why?
| Male | 10 | 2021 | 63682 | 0.100 |
Why?
| Th1 Cells | 1 | 2014 | 138 | 0.100 |
Why?
| Mesentery | 1 | 2013 | 47 | 0.100 |
Why?
| Toll-Like Receptors | 1 | 2014 | 179 | 0.100 |
Why?
| Cell Communication | 1 | 2014 | 301 | 0.100 |
Why?
| T-Lymphocytes | 1 | 2020 | 1928 | 0.090 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2014 | 324 | 0.090 |
Why?
| Gene Expression | 2 | 2014 | 1472 | 0.090 |
Why?
| Salmonella Infections, Animal | 1 | 2011 | 37 | 0.090 |
Why?
| Endocytosis | 1 | 2010 | 163 | 0.080 |
Why?
| Muramidase | 1 | 2010 | 77 | 0.080 |
Why?
| Up-Regulation | 1 | 2012 | 840 | 0.080 |
Why?
| Hypersensitivity, Delayed | 1 | 2008 | 28 | 0.080 |
Why?
| Drug Compounding | 1 | 2008 | 97 | 0.070 |
Why?
| CD4 Lymphocyte Count | 1 | 2008 | 266 | 0.070 |
Why?
| Drug Carriers | 1 | 2008 | 118 | 0.070 |
Why?
| Cell Line | 2 | 2020 | 2781 | 0.070 |
Why?
| In Vitro Techniques | 1 | 2008 | 1085 | 0.070 |
Why?
| Immunophenotyping | 2 | 2020 | 311 | 0.070 |
Why?
| Sequence Analysis, RNA | 2 | 2021 | 429 | 0.070 |
Why?
| Cell Lineage | 2 | 2020 | 333 | 0.060 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 833 | 0.060 |
Why?
| Gene Targeting | 1 | 2006 | 82 | 0.060 |
Why?
| Transcription Factors | 1 | 2014 | 1651 | 0.060 |
Why?
| HIV Infections | 1 | 2020 | 2720 | 0.060 |
Why?
| Amylases | 1 | 2005 | 17 | 0.060 |
Why?
| Phaseolus | 1 | 2005 | 5 | 0.060 |
Why?
| Interferon-gamma | 1 | 2008 | 770 | 0.060 |
Why?
| Polyethylene Terephthalates | 1 | 2025 | 21 | 0.060 |
Why?
| Helminths | 1 | 2004 | 7 | 0.060 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 177 | 0.060 |
Why?
| Insecta | 1 | 2004 | 65 | 0.060 |
Why?
| Lipopolysaccharides | 2 | 2020 | 875 | 0.060 |
Why?
| Phagocytosis | 2 | 2016 | 362 | 0.050 |
Why?
| Genetic Predisposition to Disease | 1 | 2012 | 2282 | 0.050 |
Why?
| Viruses | 1 | 2004 | 100 | 0.050 |
Why?
| Cell Death | 1 | 2025 | 354 | 0.050 |
Why?
| Drug Delivery Systems | 1 | 2006 | 336 | 0.050 |
Why?
| Toll-Like Receptor 4 | 2 | 2016 | 263 | 0.050 |
Why?
| Organoids | 1 | 2023 | 104 | 0.050 |
Why?
| Plants | 1 | 2004 | 217 | 0.050 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2025 | 396 | 0.050 |
Why?
| RNA | 2 | 2020 | 883 | 0.050 |
Why?
| Interleukins | 1 | 2023 | 241 | 0.050 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2023 | 375 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 827 | 0.050 |
Why?
| Heme Oxygenase-1 | 1 | 2021 | 62 | 0.050 |
Why?
| Antigens, Fungal | 1 | 2021 | 28 | 0.050 |
Why?
| HLA-DR3 Antigen | 1 | 2021 | 80 | 0.050 |
Why?
| Heme | 1 | 2021 | 77 | 0.050 |
Why?
| Hybridomas | 1 | 2021 | 234 | 0.050 |
Why?
| Interleukin-6 | 1 | 2025 | 720 | 0.040 |
Why?
| Pyroptosis | 1 | 2020 | 3 | 0.040 |
Why?
| Fungal Proteins | 1 | 2021 | 130 | 0.040 |
Why?
| Antigens, CD1 | 1 | 2020 | 58 | 0.040 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 43 | 0.040 |
Why?
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8 | 0.040 |
Why?
| Ketones | 1 | 2020 | 47 | 0.040 |
Why?
| Naphthalenes | 1 | 2020 | 57 | 0.040 |
Why?
| Lysophospholipids | 1 | 2020 | 72 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2020 | 160 | 0.040 |
Why?
| Homeostasis | 1 | 2023 | 611 | 0.040 |
Why?
| Smokers | 1 | 2020 | 138 | 0.040 |
Why?
| Species Specificity | 1 | 2020 | 575 | 0.040 |
Why?
| Stem Cells | 1 | 2023 | 577 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 108 | 0.040 |
Why?
| Placenta | 1 | 2025 | 723 | 0.040 |
Why?
| Down-Regulation | 1 | 2020 | 636 | 0.040 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 644 | 0.040 |
Why?
| Adult | 4 | 2021 | 35577 | 0.030 |
Why?
| Cell Membrane | 1 | 2020 | 732 | 0.030 |
Why?
| Organ Specificity | 1 | 2017 | 296 | 0.030 |
Why?
| Tryptophan | 2 | 2010 | 179 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2017 | 300 | 0.030 |
Why?
| Toll-Like Receptor 7 | 1 | 2016 | 38 | 0.030 |
Why?
| Thymocytes | 1 | 2016 | 33 | 0.030 |
Why?
| Transplantation Chimera | 1 | 2015 | 54 | 0.030 |
Why?
| Pneumonia, Viral | 1 | 2020 | 341 | 0.030 |
Why?
| Coronavirus Infections | 1 | 2020 | 335 | 0.030 |
Why?
| Genetic Variation | 1 | 2020 | 937 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2016 | 310 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2015 | 81 | 0.030 |
Why?
| Cadaver | 1 | 2016 | 306 | 0.030 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2014 | 171 | 0.030 |
Why?
| Clone Cells | 1 | 2014 | 261 | 0.030 |
Why?
| Chlamydia | 1 | 2014 | 9 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2015 | 274 | 0.030 |
Why?
| Case-Control Studies | 1 | 2021 | 3381 | 0.030 |
Why?
| Salmonella | 1 | 2014 | 59 | 0.030 |
Why?
| CD4 Antigens | 1 | 2014 | 138 | 0.030 |
Why?
| Ultraviolet Rays | 1 | 2016 | 383 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 769 | 0.030 |
Why?
| Smoking | 1 | 2020 | 1501 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 331 | 0.030 |
Why?
| Chlamydia muridarum | 1 | 2012 | 2 | 0.030 |
Why?
| Mice, Congenic | 1 | 2012 | 22 | 0.030 |
Why?
| Pulmonary Alveoli | 1 | 2015 | 400 | 0.020 |
Why?
| Interleukin-18 | 1 | 2014 | 237 | 0.020 |
Why?
| Pregnancy | 1 | 2025 | 6402 | 0.020 |
Why?
| Mice, 129 Strain | 1 | 2012 | 87 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2015 | 505 | 0.020 |
Why?
| Immunization | 1 | 2014 | 411 | 0.020 |
Why?
| Pandemics | 1 | 2020 | 1488 | 0.020 |
Why?
| Chlamydia Infections | 1 | 2012 | 73 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2014 | 352 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2017 | 1418 | 0.020 |
Why?
| Genes, MHC Class II | 1 | 2010 | 73 | 0.020 |
Why?
| Acrylamide | 1 | 2010 | 3 | 0.020 |
Why?
| Salts | 1 | 2010 | 37 | 0.020 |
Why?
| Potassium Chloride | 1 | 2010 | 40 | 0.020 |
Why?
| Protein Denaturation | 1 | 2010 | 75 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 887 | 0.020 |
Why?
| Circular Dichroism | 1 | 2010 | 148 | 0.020 |
Why?
| Middle Aged | 2 | 2021 | 31155 | 0.020 |
Why?
| Chickens | 1 | 2010 | 188 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 330 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2010 | 171 | 0.020 |
Why?
| Phenotype | 1 | 2017 | 3076 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2010 | 544 | 0.020 |
Why?
| Protein Folding | 1 | 2010 | 266 | 0.020 |
Why?
| Apoptosis | 1 | 2016 | 2503 | 0.020 |
Why?
| Protein Conformation | 1 | 2010 | 859 | 0.020 |
Why?
| Chromatography, DEAE-Cellulose | 1 | 2005 | 13 | 0.020 |
Why?
| Cystine | 1 | 2005 | 17 | 0.020 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2005 | 84 | 0.020 |
Why?
| Bacillus thuringiensis | 1 | 2004 | 5 | 0.010 |
Why?
| Molecular Weight | 1 | 2005 | 332 | 0.010 |
Why?
| Tyrosine | 1 | 2005 | 223 | 0.010 |
Why?
| Genetic Engineering | 1 | 2004 | 88 | 0.010 |
Why?
| Time Factors | 1 | 2014 | 6556 | 0.010 |
Why?
| Genetic Markers | 1 | 2004 | 338 | 0.010 |
Why?
| Genetic Vectors | 1 | 2004 | 312 | 0.010 |
Why?
| Kinetics | 1 | 2005 | 1642 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2005 | 2832 | 0.010 |
Why?
|
|
Atif's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|